Trader’s Recap: Builders FirstSource, Inc. (NASDAQ:BLDR), OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), Capitol Federal Financial, Inc. (NASDAQ:CFFN),

On 29 February, Builders FirstSource, Inc. (NASDAQ:BLDR) announced that it has entered into separate, privately negotiated exchange agreements pursuant to which $63.8 million aggregate principal amount of its 10.75% Senior Notes due 2023 (the “2023 Notes”) will be exchanged for $60.0 million aggregate principal amount of additional 7.625% Senior Secured Notes due 2021 (the “2021 Notes”) issued under its existing indenture, dated as of May 29, 2013 (the “Indenture”).

Builders FirstSource, Inc. (NASDAQ:BLDR) belongs to Industrial Goods sector. Its net profit margin is -0.40% and weekly performance is 17.92%. On last trading day company shares ended up at $8.49. Builders FirstSource, Inc. (NASDAQ:BLDR) distance from 50-day simple moving average (SMA50) is 1.06%.

On 22 February, OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) announced updated survival data from a Phase 1b clinical trial of tarextumab (anti-Notch2/3, OMP-59R5) for the treatment of small cell lung cancer.

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) shares advanced 4.62% in last trading session and ended the day at $9.97. OMED return on assets is -34.80%. OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) quarterly performance is -57.81%.

Zacks Investment Research upgraded shares of Capitol Federal Financial, Inc. (NASDAQ:CFFN) from a hold rating to a buy rating in a research note issued to investors on Thursday morning, Market Beat reports. Zacks Investment Research currently has $14.00 price objective on the stock.

On 01 March, Capitol Federal Financial, Inc. (NASDAQ:CFFN) shares advanced 0.95% and was closed at $12.69. CFFN EPS growth in last 5 year was 7.20%. Capitol Federal Financial, Inc. (NASDAQ:CFFN) year to date (YTD) performance is 1.75%.

Ericsson (NASDAQ:ERIC) has inked a five-year network enhancement contract with Telenor Group. The contract covers the design and implementation of 4G/LTE networks, along with the transformation of 2G and 3G networks in Thailand, Myanmar and Bangladesh.

Ericsson (NASDAQ:ERIC) belongs to Technology sector. Its net profit margin is 5.60% and weekly performance is 1.30%. On last trading day company shares ended up at $9.34. Ericsson (NASDAQ:ERIC) distance from 50-day simple moving average (SMA50) is 3.01%.

On 26 February, Bristol-Myers Squibb Company (NYSE:BMY) announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Opdivo (nivolumab) for two new indications – adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy, and adults with advanced renal cell carcinoma (RCC) after prior therapy. Both indications are supported by Phase 3 studies in which Opdivodemonstrated a survival benefit versus a standard of care.

Bristol-Myers Squibb Company (NYSE:BMY) shares moved up 3.70% in last trading session and ended the day at $64.22. BMY Gross Margin is 76.90% and its return on assets is 4.90%. Bristol-Myers Squibb Company (NYSE:BMY) quarterly performance is -4.83%.

Leave a Reply

Your email address will not be published. Required fields are marked *